首页 | 本学科首页   官方微博 | 高级检索  
     


An agarose spot chemotaxis assay for chemokine receptor antagonists
Authors:Vinader Victoria  Al-Saraireh Yousef  Wiggins Helen L  Rappoport Joshua Z  Shnyder Steve D  Patterson Laurence H  Afarinkia Kamyar
Affiliation:aThe Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK;bSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
Abstract:

Introduction

Chemokines are important players in directing the migration of cancer cells as part of the metastatic process. The aim of this study is to develop an easy-to-perform, reliable, and inexpensive assay for rapid analysis of anti-chemotactic activity of chemokine antagonists under a number of experimental conditions.

Methods

An agarose spot containing the chemokine chemoattractant is applied to a glass petri dish. Live cells in a media, both with and without a chemokine antagonist, are added to the dish and, following cell adhesion, the migration under the agarose spot is observed and analysed by microscopy.

Results

In the absence of CXCL12 in the agarose, no migration under the agarose spot is detected. In the presence of CXCL12, significant migration under the agarose spot is observed which can be retarded if a neutralising monoclonal antibody or a small molecule antagonist is added to the media.

Discussion

This experimental configuration is a reliable, inexpensive and easy-to-perform chemotaxis assay, which enables assessment of the activity of CXCR4 antagonists.
Keywords:Abbreviations: CXCR4, Chemokine CXC type receptor 4   CXCL12, Chemokine CXC type ligand 12 (also known as SDF1-α)   FCS, foetal calf serum   siRNA, small interfering ribonucleic acid   mAb, monoclonal antibody   GPCR, G-protein coupled receptor   FPR, formylpeptide receptor
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号